Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained humoral response 6 months after the anti-SARS-CoV-2 mRNA-BNT162b2 vaccine in haemodialysis patients: should booster vaccine doses be given to all patients at the same time?
La Milia V, Tonolo S, Luzzaro F, Bonato C, Limardo M, Longhi S, Ravasi C, Viganò S, Cavalli A. La Milia V, et al. Among authors: tonolo s. Clin Kidney J. 2022 Feb 16;15(5):1012-1014. doi: 10.1093/ckj/sfac047. eCollection 2022 May. Clin Kidney J. 2022. PMID: 35498885 Free PMC article. No abstract available.
Humoral and T-cell response to SARS-CoV-2 mRNA BNT162b2 vaccination in a cohort of kidney transplant recipients and their cohabitant living kidney donor partners.
La Milia V, Tonolo S, Luzzaro F, Bonato C, Casartelli D, Limardo M, Longhi S, Ravasi C, Viganò S, Cavalli A. La Milia V, et al. Among authors: tonolo s. Clin Kidney J. 2022 Jan 13;15(4):820-821. doi: 10.1093/ckj/sfac010. eCollection 2022 Apr. Clin Kidney J. 2022. PMID: 35371437 Free PMC article. No abstract available.
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. Luxi N, et al. Drug Saf. 2021 Dec;44(12):1247-1269. doi: 10.1007/s40264-021-01131-6. Epub 2021 Nov 5. Drug Saf. 2021. PMID: 34739716 Free PMC article. Review.
20 results